Skip to content

Growth in South Korean domestic pharma market expected, notes survey

A survey performed onsite at CPhI Korea has highlighted that domestic companies are anticipating a headline growth in the order of 16% across the South Korean pharma market.

Growth in South Korean domestic pharma market expected, notes survey
Published: | 1 min read

A survey performed onsite at CPhI Korea has highlighted that domestic companies are anticipating a headline growth in the order of 16% across the South Korean pharma market.

South Korea

The survey included both international and domestic attendees from the event, which attracted 4,300 attendees and 147 exhibitors this year.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information